Publikasjoner 2022

Colorectal Cancer Screening: Randomized Trials Are Essential to Support Recommendations. 

Bretthauer M, Schoen RE, Cross AJ, Pinsky PF. Ann Intern Med. 2022 Jan;175(1):129-130. doi: 10.7326/M21-3770. Epub 2021 Nov 9.PMID: 34748373 No abstract available.
Level 2, Impact factor 51.598

Growth Rate in Childhood and Adolescence and the Risk of Breast and Prostate Cancer: A Population-Based Study.

Haraldsdottir A, Steingrimsdottir L, Maskarinec G, Adami HO, Aspelund T, Valdimarsdottir UA, Bjarnason R, Thorsdottir I, Halldorsson TI, Gunnarsdottir I, Tryggvadottir L, Gudnason V, Birgisdottir BE, Torfadottir JE. Am J Epidemiol. 2022 Jan 24;191(2):320-330. doi: 10.1093/aje/kwab250. PMID: 34643238.
Level 2, Impact factor 5.363

Charting a path forward for clinical research in artificial intelligence and gastroenterology. 

Glissen Brown JR, Waljee AK, Mori Y, Sharma P, Berzin TM. Dig Endosc. 2022 Jan;34(1):4-12. doi: 10.1111/den.13974. Epub 2021 Apr 19. PMID: 33715244 Review.
Level 1, Impact factor 6.337

Combined endocytoscopy with pit pattern diagnosis in ulcerative colitis-associated neoplasia: Pilot study.

Kudo SE, Maeda Y, Ogata N, Misawa M, Ogawa Y, Takishima K, Ishiyama M, Mochizuki K, Minegishi Y, Ogura Y, Abe M, Okumura T, Matsudaira S, Ishigaki T, Sasanuma S, Mori Y, Kudo T, Hayashi T, Wakamura K, Miyachi H, Baba T, Ishida F, Nemoto T, Hamatani S, Ohtsuka K. Dig Endosc. 2022 Jan;34(1):133-143. doi: 10.1111/den.13964. Epub 2021 Apr 1. PMID: 33641190
Level 1, Impact factor 6.337

Tumor Location as a Prognostic Factor in T1 Colorectal Cancer. 

Ichimasa K, Kudo SE, Kouyama Y, Mochizuki K, Takashina Y, Misawa M, Mori Y, Hayashi T, Wakamura K, Miyachi H. J Anus Rectum Colon. 2022 Jan 28;6(1):9-15. doi: 10.23922/jarc.2021-029. eCollection 2022. PMID: 35128132 Free PMC article. Review.

Impact of the clinical use of artificial intelligence-assisted neoplasia detection for colonoscopy: a large-scale prospective, propensity score-matched study (with video). 

Ishiyama M, Kudo SE, Misawa M, Mori Y, Maeda Y, Ichimasa K, Kudo T, Hayashi T, Wakamura K, Miyachi H, Ishida F, Itoh H, Oda M, Mori K. Gastrointest Endosc. 2022 Jan;95(1):155-163. doi: 10.1016/j.gie.2021.07.022. Epub 2021 Aug 2. PMID: 34352255
Level 2, Impact factor 10.3963

Definition of competence standards for optical diagnosis of diminutive colorectal polyps: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. 

Houwen BBSL, Hassan C, Coupé VMH, Greuter MJE, Hazewinkel Y, Vleugels JLA, Antonelli G, Bustamante-Balén M, Coron E, Cortas GA, Dinis-Ribeiro M, Dobru DE, East JE, Iacucci M, Jover R, Kuvaev R, Neumann H, Pellisé M, Puig I, Rutter MD, Saunders B, Tate DJ, Mori Y, Longcroft-Wheaton G, Bisschops R, Dekker E. Endoscopy. 2022 Jan;54(1):88-99. doi: 10.1055/a-1689-5130. Epub 2021 Dec 6. PMID: 34872120
Level 2, Impact factor 10.437

The inflammatory response is related to circulatory failure after out-of-hospital cardiac arrest: A prospective cohort study. 

Langeland H, Damås JK, Mollnes TE, Ludviksen JK, Ueland T, Michelsen AE, Løberg M, Bergum D, Nordseth T, Skjærvold NK, Klepstad P. Resuscitation. 2022 Jan;170:115-125. doi: 10.1016/j.resuscitation.2021.11.026. Epub 2021 Nov 24.PMID: 34838662 Free article.
Level 2, Impact factor 6.251

Characteristics of circulatory failure after out-of-hospital cardiac arrest: a prospective cohort study.

Langeland H, Bergum D, Løberg M, Bjørnstad K, Skaug TR, Nordseth T, Klepstad P, Skjærvold NK. Open Heart. 2022 Jan;9(1):e001890. doi: 10.1136/openhrt-2021-001890.PMID: 35046124 Free PMC article.
Level 1, Cite score 3.9.

Excess Body Fatness during Early to Mid-Adulthood and Survival from Colorectal and Breast Cancer: A Pooled Analysis of Five International Cohort Studies.

Charvat H, Freisling H, Noh H, Gaudet MM, Gunter MJ, Cross AJ, Tsilidis KK, Tjønneland A, Katzke V, Bergmann M, Agnoli C, Rylander C, Skeie G, Jakszyn P, Rosendahl AH, Sund M, Severi G, Tsugane S, Sawada N, Brenner H, Adami HO, Weiderpass E, Soerjomataram I, Arnold M. Cancer Epidemiol Biomarkers Prev. 2022 Feb;31(2):325-333. doi: 10.1158/1055-9965.EPI-21-0688. Epub 2021 Nov 15. PMID: 34782393; PMCID: PMC7612347.
Level 1, Impact factor 4.090

Letter: towards gender-stratified colorectal cancer screening and surveillance? Authors' reply.

Jodal HC, Løberg M. Aliment Pharmacol Ther. 2022 Feb;55(4):506-507. doi: 10.1111/apt.16764.PMID: 35092055 No abstract available.
Level 1, Impact factor 9.524

Lifestyle predictors for inconsistent participation to fecal based colorectal cancer screening.

Knudsen MD, Kvaerner AS, Botteri E, Holme Ø, Hjartåker A, Song M, Thiis-Evensen E, Randel KR, Hoff G, Berstad P. BMC Cancer. 2022 Feb 15;22(1):172. doi: 10.1186/s12885-022-09287-9.PMID: 35168592 Free PMC article.
Level 1, Impact factor 4.638

ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: Updated guidance for the era of vaccines and viral variants.

Gralnek IM, Hassan C, Ebigbo A, Fuchs A, Beilenhoff U, Antonelli G, Bisschops R, Arvanitakis M, Bhandari P, Bretthauer M, Kaminski MF, Lorenzo-Zuniga V, Rodriguez de Santiago E, Siersema PD, Tham TC, Triantafyllou K, Tringali A, Voiosu A, Webster G, de Pater M, Fehrke B, Gazic M, Gjergek T, Maasen S, Waagenes W, Dinis-Ribeiro M, Messmann H. Endoscopy. 2022 Feb;54(2):211-216. doi: 10.1055/a-1700-4897. Epub 2021 Dec 21.PMID: 34933373 Free article. No abstract available.
Level 2, Impact factor 10.437

Mortality in Norway and Sweden during the COVID-19 pandemic.

Juul FE, Jodal HC, Barua I, Refsum E, Olsvik Ø, Helsingen LM, Løberg M, Bretthauer M, Kalager M, Emilsson L. Scand J Public Health. 2022 Feb;50(1):38-45. doi: 10.1177/14034948211047137. Epub 2021 Oct 5.PMID: 34609261 Free PMC article.
Level 1, Impact factor 3.199

A novel intragastric balloon for treatment of obesity and type 2 diabetes. A two-center pilot trial.

Tønnesen CJ, Hjelmesæth J, Hofsø D, Tonstad S, Hertel JK, Heggen E, Johnson LK, Mathisen TE, Kalager M, Wieszczy P, Medhus AW, Løberg M, Aabakken L, Bretthauer M. Scand J Gastroenterol. 2022 Feb;57(2):232-238. doi: 10.1080/00365521.2021.1994641. Epub 2021 Oct 29.PMID: 34714203 Clinical Trial.
Level 1, Impact factor 3.027

Long-term colorectal cancer incidence and mortality after adenoma removal in women and men.

Jodal HC, Klotz D, Herfindal M, Barua I, Tag P, Helsingen LM, Refsum E, Holme Ø, Adami HO, Bretthauer M, Kalager M, Løberg M. Aliment Pharmacol Ther. 2022 Feb;55(4):412-421. doi: 10.1111/apt.16686. Epub 2021 Oct 30.PMID: 34716941
Level 1, Impact factor 9.524

Artificial intelligence in colonoscopy: A review on the current status.

Larsen SLV, Mori Y. DEN Open. 2022 Mar 23;2(1):e109. doi: 10.1002/deo2.109. eCollection 2022 Apr. PMID: 35873511 Free PMC article. Review.
Level 1

Association between total and leisure time physical activity and risk of myocardial infarction and stroke - a Swedish cohort study.

Hummel M, Hantikainen E, Adami HO, Ye W, Bellocco R, Bonn SE, Lagerros YT. BMC Public Health. 2022 Mar 18;22(1):532. doi: 10.1186/s12889-022-12923-5. PMID: 35303845; PMCID: PMC8932168.
Level 1, Impact factor 4.135

Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.

Yu J, Refsum E, Helsingen LM, Folseraas T, Ploner A, Wieszczy P, Barua I, Jodal HC, Melum E, Løberg M, Blom J, Bretthauer M, Adami HO, Kalager M, Ye W. United European Gastroenterol J. 2022 Mar;10(2):212-224. doi: 10.1002/ueg2.12204. Epub 2022 Feb 2.PMID: 35107865 Free PMC article.
Level 1, Impact factor 6.866

Seroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21.

Anda EE, Braaten T, Borch KB, Nøst TH, Chen SLF, Lukic M, Lund E, Forland F, Leon DA, Winje BA, Kran AB, Kalager M, Johansen FL, Sandanger TM. Euro Surveill. 2022 Mar;27(13):2100376. doi: 10.2807/1560-7917.ES.2022.27.13.2100376.PMID: 35362405 Free PMC article.
Level 1, Impact factor 11.622  

Influence of Pre-treatment Saliva Microbial Diversity and Composition on Nasopharyngeal Carcinoma Prognosis.

Du Y, Feng R, Chang ET, Debelius JW, Yin L, Xu M, Huang T, Zhou X, Xiao X, Li Y, Liao J, Zheng Y, Huang G, Adami HO, Zhang Z, Cai Y, Ye W. Front Cell Infect Microbiol. 2022 Mar 22;12:831409. doi: 10.3389/fcimb.2022.831409. PMID: 35392614; PMCID: PMC8981580.
Level 1, Impact factor 6.073

Environmental Factors for Epstein-Barr Virus Reactivation in a High-Risk Area of Nasopharyngeal Carcinoma: A Population-Based Study.

Chen Y, Chang ET, Liu Q, Cai Y, Zhang Z, Chen G, Huang QH, Xie SH, Cao SM, Jia WH, Zheng Y, Li Y, Lin L, Ernberg I, Huang G, Zeng YX, Adami HO, Ye W. Open Forum Infect Dis. 2022 Mar 15;9(5):ofac128. doi: 10.1093/ofid/ofac128. PMID: 35450082; PMCID: PMC9017372.
Level 1, Impact factor 4.423

Impact of time between faecal immunochemical tests in colorectal cancer screening on screening results: A natural experiment.

Ribe SG, Botteri E, Løberg M, Randel KR, Kalager M, Nilsen JA, Gulichsen EH, Holme Ø. Int J Cancer. 2023 Apr 1;152(7):1414-1424. doi: 10.1002/ijc.34351. Epub 2022 Nov 21.PMID: 36346118
Level 2, Impact factor 7.316

Correction: Endoscopists' diagnostic accuracy in detecting upper gastrointestinal neoplasia in the framework of artificial intelligence studies. 

Frazzoni L, Arribas J, Antonelli G, Libanio D, Ebigbo A, van der Sommen F, de Groof AJ, Fukuda H, Ohmori M, Ishihara R, Wu L, Yu H, Mori Y, Repici A, Bergman JJGHM, Sharma P, Messmann H, Hassan C, Fuccio L, Dinis-Ribeiro M. Endoscopy. 2022 Apr;54(4):C12. doi: 10.1055/a-1907-9242. Epub 2022 Aug 1. PMID: 35915991 No abstract available.
Level 2, Impact factor 10.437

App-based COVID-19 syndromic surveillance and prediction of hospital admissions in COVID Symptom Study Sweden.

Kennedy B, Fitipaldi H, Hammar U, Maziarz M, Tsereteli N, Oskolkov N, Varotsis G, Franks CA, Nguyen D, Spiliopoulos L, Adami HO, Björk J, Engblom S, Fall K, Grimby-Ekman A, Litton JE, Martinell M, Oudin A, Sjöström T, Timpka T, Sudre CH, Graham MS, du Cadet JL, Chan AT, Davies R, Ganesh S, May A, Ourselin S, Pujol JC, Selvachandran S, Wolf J, Spector TD, Steves CJ, Gomez MF, Franks PW, Fall T. Nat Commun. 2022 Apr 21;13(1):2110. doi: 10.1038/s41467-022-29608-7. PMID: 35449172; PMCID: PMC9023535.
Level 2, Impact factor 17.694

Ranitidine Use and Risk of Upper Gastrointestinal Cancers-Reply. Cancer Epidemiol Biomarkers.

Adami HO, Andersen IT, Heide-Jørgensen U, Nørgaard M, Sørensen HT. Prev. 2022 Apr 1;31(4):915. doi: 10.1158/1055-9965.EPI-22-0081. PMID: 35373261.
Level 1, Impact factor 2.89

Endoscopists' diagnostic accuracy in detecting upper gastrointestinal neoplasia in the framework of artificial intelligence studies.

Frazzoni L, Arribas J, Antonelli G, Libanio D, Ebigbo A, van der Sommen F, de Groof AJ, Fukuda H, Ohmori M, Ishihara R, Wu L, Yu H, Mori Y, Repici A, Bergman JJGHM, Sharma P, Messmann H, Hassan C, Fuccio L, Dinis-Ribeiro M. Endoscopy. 2022 Apr;54(4):403-411. doi: 10.1055/a-1500-3730. Epub 2021 Jun 17. PMID: 33951743
Level 2, Impact factor 10.437

Evaluation in real-time use of artificial intelligence during colonoscopy to predict relapse of ulcerative colitis: a prospective study. 

Maeda Y, Kudo SE, Ogata N, Misawa M, Iacucci M, Homma M, Nemoto T, Takishima K, Mochida K, Miyachi H, Baba T, Mori K, Ohtsuka K, Mori Y. Gastrointest Endosc. 2022 Apr;95(4):747-756.e2. doi: 10.1016/j.gie.2021.10.019. Epub 2021 Oct 22. PMID: 34695422
Level 2, Impact factor 10.3963

A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening.

He YQ, Wang TM, Ji M, Mai ZM, Tang M, Wang R, Zhou Y, Zheng Y, Xiao R, Yang D, Wu Z, Deng C, Zhang J, Xue W, Dong S, Zhan J, Cai Y, Li F, Wu B, Liao Y, Zhou T, Zheng M, Jia Y, Li D, Cao L, Yuan L, Zhang W, Luo L, Tong X, Wu Y, Li X, Zhang P, Zheng X, Zhang S, Hu Y, Qin W, Deng B, Liang X, Fan P, Feng Y, Song J, Xie SH, Chang ET, Zhang Z, Huang G, Xu M, Feng L, Jin G, Bei J, Cao S, Liu Q, Kozlakidis Z, Mai H, Sun Y, Ma J, Hu Z, Liu J, Lung ML, Adami HO, Shen H, Ye W, Lam TH, Zeng YX, Jia WH. Nat Commun. 2022 Apr 12;13(1):1966. doi: 10.1038/s41467-022-29570-4. PMID: 35414057; PMCID: PMC9005522.
Level 2, Impact factor 17.694

Real-Time Artificial Intelligence–Based Optical Diagnosis of Neoplastic Polyps during Colonoscopy | NEJM Evidence

Ishita Barua, M.D, Paulina Wieszczy, Ph.D, Shin-ei Kudo, M.D, Masashi Misawa, M.D, Øyvind Holme, M.D, Shraddha Gulati, M.D, Sophie Williams, M.D, Kensaku Mori, Ph.D, Hayato Itoh, Ph.D, Kazumi Takishima, M.D, Kenichi Mochizuki, M.D, Yuki Miyata, M.D, Kentaro Mochida, M.D, Yoshika Akimoto, M.D, Takanori Kuroki, M.D, Yuriko Morita, M.D, Osamu Shiina, M.D, Shun Kato, M.D, Tetsuo Nemoto, M.D, Bu Hayee, M.D, Mehul Patel, M.D, Nishmi Gunasingam, M.D, Alexandra Kent, M.D, Andrew Emmanuel, M.D, Carl Munck, M.D, Jens Aksel Nilsen, M.D, Stine Astrup Hvattum, M.D, Svein Oskar Frigstad, M.D, Petter Tandberg, M.D, Magnus Løberg, M.D, Mette Kalager, M.D, Amyn Haji, M.D, Michael Bretthauer, M.D, and Yuichi Mori, M.D.Published April 13, 2022, NEJM Evid 2022; DOI:https://doi.org/10.1056/EVIDoa2200003
Level 1, Impact factor 91.245

Letter: long-term colorectal cancer incidence and mortality after adenoma removal associated with heritable factors, colonoscopic surveillance and aspirin-authors' reply.

Jodal HC, Bretthauer M, Kalager M, Løberg M. Aliment Pharmacol Ther. 2022 May;55(10):1363-1364. doi: 10.1111/apt.16929.PMID: 35472187 No abstract available.
Level 1, Impact factor 9.524

Comparing the number and relevance of false activations between 2 artificial intelligence computer-aided detection systems: the NOISE study. 

Spadaccini M, Hassan C, Alfarone L, Da Rio L, Maselli R, Carrara S, Galtieri PA, Pellegatta G, Fugazza A, Koleth G, Emmanuel J, Anderloni A, Mori Y, Wallace MB, Sharma P, Repici A. Gastrointest Endosc. 2022 May;95(5):975-981.e1. doi: 10.1016/j.gie.2021.12.031. Epub 2022 Jan 4. PMID: 34995639
Level 2, Impact factor 10.3963

Commentary in Endoscopy.

Hassan C, Mori Y, Repici A. Endoscopy. 2022 May;54(5):521. doi: 10.1055/a-1736-8097. Epub 2022 Apr 21. PMID: 35448906 No abstract available.

Level 2, Impact factor 10.437

Digestive cancer screening across Europe.

Burra P, Bretthauer M, Buti Ferret M, Dugic A, Fracasso P, Leja M, Matysiak Budnik T, Michl P, Ricciardiello L, Seufferlein T, van Leerdam M, Botos A. United European Gastroenterol J. 2022 May;10(4):435-437. doi: 10.1002/ueg2.12230. Epub 2022 Apr 26.PMID: 35474447 Free PMC article. No abstract available.
Level 1, Impact factor 6.866

How to Integrate Artificial Intelligence in Gastrointestinal Practice. 

Messmann H, Ebigbo A, Hassan C, Repici A, Mori Y. Gastroenterology. 2022 May;162(6):1583-1586. doi: 10.1053/j.gastro.2022.02.029. Epub 2022 Feb 20. PMID: 35196540 No abstract available.
Level 2, Impact factor 33.883

Dietary fat intake and risk of Parkinson disease: results from the Swedish National March Cohort.

Hantikainen E, Roos E, Bellocco R, D'Antonio A, Grotta A, Adami HO, Ye W, Trolle Lagerros Y, Bonn S. Eur J Epidemiol. 2022 Jun;37(6):603-613. doi: 10.1007/s10654-022-00863-8. Epub 2022 Apr 13. PMID: 35416636; PMCID: PMC9288363.

Level 2, Impact factor 12.442

Inflammatory bowel disease and risk of adenocarcinoma and neuroendocrine tumors in the small bowel.

Yu J, Refsum E, Perrin V, Helsingen LM, Wieszczy P, Løberg M, Bretthauer M, Adami HO, Ye W, Blom J, Kalager M. Ann Oncol. 2022 Jun;33(6):649-656. doi: 10.1016/j.annonc.2022.02.226. Epub 2022 Mar 8.PMID: 35276334 Free article.
Level 2, Impact factor 51.769

Although depth prediction of colorectal cancer with artificial intelligence is clinically relevant, standardization of histopathologic diagnosis should also be taken care of.

Saito Y, Yamada M, Mori Y. Gastrointest Endosc. 2022 Jun;95(6):1195-1197. doi: 10.1016/j.gie.2022.02.008. Epub 2022 Mar 29. PMID: 35365318 No abstract available.
Level 2, Impact factor 10.3963

Cost-effectiveness of artificial intelligence for screening colonoscopy: a modelling study.

Areia M, Mori Y, Correale L, Repici A, Bretthauer M, Sharma P, Taveira F, Spadaccini M, Antonelli G, Ebigbo A, Kudo SE, Arribas J, Barua I, Kaminski MF, Messmann H, Rex DK, Dinis-Ribeiro M, Hassan C. Lancet Digit Health. 2022 Jun;4(6):e436-e444. doi: 10.1016/S2589-7500(22)00042-5. Epub 2022 Apr 13.PMID: 35430151 Free article.
Level 1, Impact factor 36.615

A progressive three-state model to estimate time to cancer: a likelihood-based approach.

Akwiwu EU, Klausch T, Jodal HC, Carvalho B, Løberg M, Kalager M, Berkhof J, Coupé VMH. BMC Med Res Methodol. 2022 Jun 27;22(1):179. doi: 10.1186/s12874-022-01645-2.PMID: 35761181 Free PMC article.
Level 1, Impact factor 4.622

Cancer outcome research - a European challenge Part II: Opportunities and priorities.

Kalager M, Adami HO, Dickman PW, Lagergren P, Steindorf K. Mol Oncol. 2022 Jun;16(12):2300-2311. doi: 10.1002/1878-0261.13169. Epub 2022 Jan 14.PMID: 34939327 Free PMC article. Review.
Level 1, Impact factor 7.449

Sleep duration and mortality, influence of age, retirement, and occupational group.

Åkerstedt T, Trolle-Lagerros Y, Widman L, Ye W, Adami HO, Bellocco R. J Sleep Res. 2022 Jun;31(3):e13512. doi: 10.1111/jsr.13512. Epub 2021 Nov 6. PMID: 34741361.
Level 1, Impact factor 5.296

Artificial Intelligence Improves Detection at Colonoscopy: Why Aren't We All Already Using It? 

Rex DK, Berzin TM, Mori Y. Gastroenterology. 2022 Jul;163(1):35-37. doi: 10.1053/j.gastro.2022.04.042. Epub 2022 Apr 29. PMID: 35500615 No abstract available.
Level 2, Impact factor 33.883

Current problems and perspectives of pathological risk factors for lymph node metastasis in T1 colorectal cancer: Systematic review.

Ichimasa K, Kudo SE, Miyachi H, Kouyama Y, Mochizuki K, Takashina Y, Maeda Y, Mori Y, Kudo T, Miyata Y, Akimoto Y, Kataoka Y, Kubota T, Nemoto T, Ishida F, Misawa M. Dig Endosc. 2022 Jul;34(5):901-912. doi: 10.1111/den.14220. Epub 2022 Jan 11. PMID: 34942683 Review.
Level 1, Impact factor 6.337

Beyond complete endoscopic healing: Goblet appearance using an endocytoscope to predict future sustained clinical remission in ulcerative colitis. 

Takishima K, Maeda Y, Ogata N, Misawa M, Mori Y, Homma M, Nemoto T, Miyata Y, Akimoto Y, Mochida K, Takashina Y, Tanaka K, Ichimasa K, Nakamura H, Sasanuma S, Kudo T, Hayashi T, Wakamura K, Miyachi H, Baba T, Ishida F, Ohtsuka K, Kudo SE. Dig Endosc. 2022 Jul;34(5):1030-1039. doi: 10.1111/den.14202. Epub 2021 Dec 12. PMID: 34816494
Level 1, Impact factor 6.337

Cancer risk in individuals with autism spectrum disorder.

Liu Q, Yin W, Meijsen JJ, Reichenberg A, Gådin JR, Schork AJ, Adami HO, Kolevzon A, Sandin S, Fang F. Ann Oncol. 2022 Jul;33(7):713-719. doi: 10.1016/j.annonc.2022.04.006. Epub 2022 Apr 14. PMID: 35430370.
Level 2, Impact factor 51.769

Cancer in twin pairs discordant for smoking: The Nordic Twin Study of Cancer.

Korhonen T, Hjelmborg J, Harris JR, Clemmensen S, Adami HO, Kaprio J; Nordic Twin Study of Cancer (NorTwinCan) collaboration. Int J Cancer. 2022 Jul 1;151(1):33-43. doi: 10.1002/ijc.33963. Epub 2022 Feb 24. PMID: 35143046; PMCID: PMC9304125.
Level 2, Impact factor 7.316

Prevalence and risk factors of upper gastrointestinal cancers missed during endoscopy: a nationwide registry-based study.

Januszewicz W, Witczak K, Wieszczy P, Socha M, Turkot MH, Wojciechowska U, Didkowska J, Kaminski MF, Regula J.  Endoscopy. 2022 Jul;54(7):653-660. doi: 10.1055/a-1675-4136. Epub 2021 Dec 16. PMID: 34674210.
Level 2, Impact factor 10.437

A novel causal model for nasopharyngeal carcinoma. Cancer Causes Control.

Chang ET, Ye W, Ernberg I, Zeng YX, Adami HO. 2022 Jul;33(7):1013-1018. doi: 10.1007/s10552-022-01582-x. Epub 2022 Apr 19. PMID: 35441278.
Level 1, Impact factor 2.532 

Reducing the environmental footprint of gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Position Statement.

Rodríguez de Santiago E, Dinis-Ribeiro M, Pohl H, Agrawal D, Arvanitakis M, Baddeley R, Bak E, Bhandari P, Bretthauer M, Burga P, Donnelly L, Eickhoff A, Hayee B, Kaminski MF, Karlović K, Lorenzo-Zúñiga V, Pellisé M, Pioche M, Siau K, Siersema PD, Stableforth W, Tham TC, Triantafyllou K, Tringali A, Veitch A, Voiosu AM, Webster GJ, Vienne A, Beilenhoff U, Bisschops R, Hassan C, Gralnek IM, Messmann H. Endoscopy. 2022 Aug;54(8):797-826. doi: 10.1055/a-1859-3726. Epub 2022 Jul 8.PMID: 35803275 Free article.
Level 2, Impact factor 10.437

Emergency hospital admissions, prognosis, and population mortality in Norway during the first wave of the Covid-19 epidemic.

Jodal HC, Juul FE, Barua I, Bretthauer M, Kalager M, Løberg M, Emilsson L. Scand J Public Health. 2022 Aug;50(6):795-802. doi: 10.1177/14034948221082959. Epub 2022 May 12.PMID: 35546560 Free PMC article.
Level 1, Impact factor 3.199

Artificial intelligence for disease diagnosis: the criterion standard challenge.

Mori Y, Misawa M, Bernal J, Bretthauer M, Kudo SE, Rastogi A, Fernández-Esparrach G. Gastrointest Endosc. 2022 Aug;96(2):370-372. doi: 10.1016/j.gie.2022.04.057. Epub 2022 Apr 28.PMID: 35489396 Free article. No abstract available.

Level 2, Impact factor 10.396

Strengths and Weaknesses of an Artificial Intelligence Polyp Detection Program as Assessed by a High-Detecting Endoscopist. 

Rex DK, Mori Y, Sharma P, Lahr RE, Vemulapalli KC, Hassan C. Gastroenterology. 2022 Aug;163(2):354-358.e1. doi: 10.1053/j.gastro.2022.03.055. Epub 2022 Apr 12. PMID: 35427574 No abstract available.
Level 2, Impact factor 33.883

Impact of Artificial Intelligence on Colonoscopy Surveillance After Polyp Removal: A Pooled Analysis of Randomized Trials.

Mori Y, Wang P, Løberg M, Misawa M, Repici A, Spadaccini M, Correale L, Antonelli G, Yu H, Gong D, Ishiyama M, Kudo SE, Kamba S, Sumiyama K, Saito Y, Nishino H, Liu P, Glissen Brown JR, Mansour NM, Gross SA, Kalager M, Bretthauer M, Rex DK, Sharma P, Berzin TM, Hassan C. Clin Gastroenterol Hepatol. 2022 Aug 28:S1542-3565(22)00818-7. doi: 10.1016/j.cgh.2022.08.022. Online ahead of print.PMID: 36038128 Free article.
Level 1, Impact factor 13.576

Characteristics of nonparticipants in a randomised colorectal cancer screening trial comparing sigmoidoscopy and faecal immunochemical testing.

Botteri E, Hoff G, Randel KR, Holme Ø, de Lange T, Bernklev T, Aas E, Berthelsen M, Natvig E, Kirkøen B, Knudsen MD, Kvaerner AS, Schult AL, Ursin G, Jørgensen A, Berstad P. Int J Cancer. 2022 Aug 1;151(3):361-371. doi: 10.1002/ijc.34025. Epub 2022 Apr 22.PMID: 35411554 Free PMC article.
Level 2, Impact factor 7.316

Hospital-Treated Infections and Increased Risk of Two EBV-Related Malignancies: A Nested Case-Control Study.

Yang Y, Yin L, Liu Q, Sun J, Adami HO, Ye W, Zhang Z, Fang F. Cancers (Basel). 2022 Aug 5;14(15):3804. doi: 10.3390/cancers14153804. PMID: 35954467; PMCID: PMC9367337.
Level 1, Impact factor 6.575

Clinical trial designs for artificial intelligence in gastrointestinal endoscopy.

Mori Y, Kaminski MF, Hassan C, Bretthauer M. Lancet Gastroenterol Hepatol. 2022 Sep;7(9):785-786. doi: 10.1016/S2468-1253(22)00232-1.PMID: 35932767 No abstract available.
Level 2, Impact factor 45.042

High-quality Studies of Artificial Intelligence in Colonoscopy Illuminate a Next Important Step.

Ahuja A, Mori Y. Gastroenterology. 2022 Sep;163(3):582-583. doi: 10.1053/j.gastro.2022.06.074. Epub 2022 Jul 1. PMID: 35780871 No abstract available.
Level 2, Impact factor 33.883

Randomized Trial for Weight Loss Using a Digital Therapeutic Application.

Thorgeirsson T, Torfadottir JE, Egilsson E, Oddsson S, Gunnarsdottir T, Aspelund T, Olafsdottir AS, Valdimarsdottir UA, Kawachi I, Adami HO, Bjarnason RG. J Diabetes Sci Technol. 2022 Sep;16(5):1150-1158. doi: 10.1177/19322968211000815. Epub 2021 Mar 19. PMID: 33736484; PMCID: PMC9445341.
Level 1, Impact factor 3.123

Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE). Quality Improvement Initiative.

Dekker E, Nass KJ, Iacucci M, Murino A, Sabino J, Bugajski M, Carretero C, Cortas G, Despott EJ, East JE, Kaminski MF, Karstensen JG, Keuchel M, Löwenberg M, Monged A, Nardone OM, Neumann H, Omar MM, Pellisé M, Peyrin-Biroulet L, Rutter MD, Bisschops R. Endoscopy. 2022 Sep;54(9):904-915. doi: 10.1055/a-1874-0946. Epub 2022 Jul 29. PMID: 35913069.
Level 2, Impact factor 10.437

Post-endoscopy Barrett's neoplasia after a negative index endoscopy: a systematic review and proposal for definitions and performance measures in endoscopy.

Desai M, Lieberman D, Srinivasan S, Nutalapati V, Challa A, Kalgotra P, Sundaram S, Repici A, Hassan C, Kaminski MF, Sharma P. Endoscopy. 2022 Sep;54(9):881-889. doi: 10.1055/a-1729-8066. Epub 2022 Jan 3. PMID: 34979570.
Level 2, Impact factor 10.437

Transcriptome-wide association analysis identified candidate susceptibility genes for nasopharyngeal carcinoma.

He YQ, Xue WQ, Li DH, Wang TM, Mai ZM, Yang DW, Deng CM, Liao Y, Zhang WL, Xiao RW, Luo L, Diao H, Tong X, Wu Y, Zhang JB, Zhou T, Li XZ, Zhang PF, Zheng XH, Zhang SD, Hu YZ, Tang M, Zheng Y, Cai Y, Chang ET, Zhang Z, Huang G, Cao SM, Liu Q, Feng L, Sun Y, Lung ML, Adami HO, Ye W, Lam TH, Jia WH. Cancer Commun (Lond). 2022 Sep;42(9):887-891. doi: 10.1002/cac2.12317. Epub 2022 Jun 1. PMID: 35642693; PMCID: PMC9456698.
Level 1, Impact factor 15.283

Impact of artificial intelligence on colorectal polyp detection for early-career endoscopists: an international comparative study.

Ainechi D, Misawa M, Barua I, Larsen SLV, Paulsen V, Garborg KK, Aabakken L, Tønnesen CJ, Løberg M, Kalager M, Kudo SE, Hotta K, Ohtsuka K, Saito S, Ikematsu H, Saito Y, Matsuda T, Itoh H, Mori K, Bretthauer M, Mori Y. Scand J Gastroenterol. 2022 Oct;57(10):1272-1277. doi: 10.1080/00365521.2022.2070436. Epub 2022 May 23.PMID: 35605150
Level 1, Impact factor 3.027

Novel "resect and analysis" approach for T2 colorectal cancer with use of artificial intelligence.

Ichimasa K, Nakahara K, Kudo SE, Misawa M, Bretthauer M, Shimada S, Takehara Y, Mukai S, Kouyama Y, Miyachi H, Sawada N, Mori K, Ishida F, Mori Y. Gastrointest Endosc. 2022 Oct;96(4):665-672.e1. doi: 10.1016/j.gie.2022.04.1305. Epub 2022 Apr 30.PMID: 35500659
Level 2, Impact factor 10.39

Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.

Bretthauer M, Løberg M, Wieszczy P, Kalager M, Emilsson L, Garborg K, Rupinski M, Dekker E, Spaander M, Bugajski M, Holme Ø, Zauber AG, Pilonis ND, Mroz A, Kuipers EJ, Shi J, Hernán MA, Adami HO, Regula J, Hoff G, Kaminski MF; NordICC Study Group. N Engl J Med. 2022 Oct 27;387(17):1547-1556. doi: 10.1056/NEJMoa2208375. Epub 2022 Oct 9.PMID: 36214590 Clinical Trial.
Level 2, Impact factor 176.079

Rates of repeated colonoscopies to clean the colon from low-risk and high-risk adenomas: results from the EPoS trials.

Juul FE, Garborg K, Nesbakken E, Løberg M, Wieszczy P, Cubiella J, Kalager M, Kaminski MF, Erichsen R, Adami HO, Ferlitsch M, Furholm SKB, Zauber AG, Quintero E, Bugajski M, Holme Ø, Dekker E, Jover R, Bretthauer M. Gut. 2022 Oct 28:gutjnl-2022-327696. doi: 10.1136/gutjnl-2022-327696. Online ahead of print.PMID: 36307178
Level 2, Impact factor 31.795

Complete polyp resection with cold snare versus hot snare polypectomy for polyps of 4-9 mm: a randomized controlled trial.

Pedersen IB, Rawa-Golebiewska A, Calderwood AH, Brix LD, Grode LB, Botteri E, Bugajski M, Kaminski MF, Januszewicz W, Ødegaard H, Kleist B, Kalager M, Løberg M, Bretthauer M, Hoff G, Medhus A, Holme Ø. Endoscopy. 2022 Oct;54(10):961-969. doi: 10.1055/a-1734-7952. Epub 2022 Jan 10.PMID: 35008112 Free article. Clinical Trial.
Level 2, Impact factor 10.437

The impact of driving time on participation in colorectal cancer screening with sigmoidoscopy and faecal immunochemical blood test.

Berthelsen M, Berstad P, Randel KR, Hoff G, Natvig E, Holme Ø, Botteri E.Cancer Epidemiol. 2022 Oct;80:102244. doi: 10.1016/j.canep.2022.102244. Epub 2022 Aug 31.PMID: 36057171 Free article. Clinical Trial.
Level 1, Impact factor 2.89

Endoscopists performance in optical diagnosis of colorectal polyps in artificial intelligence studies. 

Pecere S, Antonelli G, Dinis-Ribeiro M, Mori Y, Hassan C, Fuccio L, Bisschops R, Costamagna G, Jin EH, Lee D, Misawa M, Messmann H, Iacopini F, Petruzziello L, Repici A, Saito Y, Sharma P, Yamada M, Spada C, Frazzoni L. United European Gastroenterol J. 2022 Oct;10(8):817-826. doi: 10.1002/ueg2.12285. Epub 2022 Aug 19. PMID: 35984903 Free PMC article. Review.
Level 1, Impact factor 6.866

Identification of a small, depressed type of colorectal invasive cancer by an artificial intelligence-assisted detection system. 

Kudo SE, Misawa M, Mori Y, Kawabata Y, Maeda Y, Miyachi H, Mori K. Endoscopy. 2022 Oct;54(10):E592-E593. doi: 10.1055/a-1704-8103. Epub 2021 Dec 21. PMID: 34933368 No abstract available.
Level 2, Impact factor 10.437

Type and Severity of Mental Illness and Participation in Colorectal Cancer Screening.

Kirkøen B, Berstad P, Hoff G, Bernklev T, Randel KR, Holme Ø, de Lange T, Robb KA, Botteri E. Am J Prev Med. 2023 Jan;64(1):76-85. doi: 10.1016/j.amepre.2022.08.011. Epub 2022 Oct 8.PMID: 36216655 Free article.
Level 1, Impact factor 6.604

15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality : A Pooled Analysis of Randomized Trials.

Juul FE, Cross AJ, Schoen RE, Senore C, Pinsky P, Miller E, Segnan N, Wooldrage K, Wieszczy-Szczepanik P, Armaroli P, Garborg KK, Adami HO, Hoff G, Kalager M, Bretthauer M, Løberg M, Holme Ø. Ann Intern Med. 2022 Nov;175(11):1525-1533. doi: 10.7326/M22-0835. Epub 2022 Oct 11.PMID: 36215714
Level 2, Impact factor 51.598

Authors response to Brenner

Juul FE, Cross AJ, Schoen RE, Senore C, Løberg M. Ann Intern Med. 15 November 2022. 
Level 2, Impact factor 51.598

Variability in adenoma detection rate in control groups of randomized colonoscopy trials: a systematic review and meta-analysis.

Hassan C, Piovani D, Spadaccini M, Parigi T, Khalaf K, Facciorusso A, Fugazza A, Rösch T, Bretthauer M, Mori Y, Sharma P, Rex DK, Bonovas S, Repici A. Gastrointest Endosc. 2023 Feb;97(2):212-225.e7. doi: 10.1016/j.gie.2022.10.009. Epub 2022 Oct 13.PMID: 36243103 Review.
Level 2, Impact factor 10.396

Comparative Performance of Artificial Intelligence Optical Diagnosis Systems for Leaving in Situ Colorectal Polyps.

Hassan C, Sharma P, Mori Y, Bretthauer M, Rex DK; Combo Study Group; Repici A. Gastroenterology. 2022 Nov 1:S0016-5085(22)01199-4. doi: 10.1053/j.gastro.2022.10.021. Online ahead of print.PMID: 36328079 No abstract available.
Level 2, Impact factor 33.883

Artificial intelligence in gastroenterology: Where are we heading?

Koleth G, Emmanue J, Spadaccini M, Mascagni P, Khalaf K, Mori Y, Antonelli G, Maselli R, Carrara S, Galtieri PA, Pellegatta G, Fugazza A, Anderloni A, Selvaggio C, Bretthauer M, Aghemo A, Spinelli A, Savevski V, Sharma P, Hassan C, Repici A. Endosc Int Open. 2022 Nov 15;10(11):E1474-E1480. doi: 10.1055/a-1907-6569. eCollection 2022 Nov.PMID: 36397868 Free PMC article.
Level 1

Use of advanced endoscopic technology for optical characterization of neoplasia in patients with ulcerative colitis: Systematic review. 

Maeda Y, Kudo SE, Ogata N, Kuroki T, Takashina Y, Takishima K, Ogawa Y, Ichimasa K, Mori Y, Kudo T, Hayashi T, Miyachi H, Ishida F, Nemoto T, Ohtsuka K, Misawa M. Dig Endosc. 2022 Nov;34(7):1297-1310. doi: 10.1111/den.14335. Epub 2022 Jun 2. PMID: 35445457 Review.
Level 1, Impact factor 6.337

Positive-gradient-weighted object activation mapping: visual explanation of object detector towards precise colorectal-polyp localisation. 

Itoh H, Misawa M, Mori Y, Kudo SE, Oda M, Mori K. Int J Comput Assist Radiol Surg. 2022 Nov;17(11):2051-2063. doi: 10.1007/s11548-022-02696-y. Epub 2022 Aug 8. PMID: 35939251
Level 1, Impact factor 3.421

UEG position paper: Obesity and digestive health.

Burra P, Arvanitakis M, Dias JA, Bretthauer M, Dugic A, Hartmann D, Michl P, Seufferlein T, Torres J, Törnblom H, van Leerdam ME, Zelber-Sagi S, Botos A. United European Gastroenterol J. 2022 Dec;10(10):1199-1201. doi: 10.1002/ueg2.12334. Epub 2022 Dec 1.PMID: 36457185 Free PMC article.
Level 1, Impact factor 6.866

Speedometer for withdrawal time monitoring during colonoscopy: a clinical implementation trial.

Barua I, Misawa M, Glissen Brown JR, Walradt T, Kudo SE, Sheth SG, Nee J, Iturrino J, Mukherjee R, Cheney CP, Sawhney MS, Pleskow DK, Mori K, Løberg M, Kalager M, Wieszczy P, Bretthauer M, Berzin TM, Mori Y. Scand J Gastroenterol. 2022 Dec 15:1-7. doi: 10.1080/00365521.2022.2154616. Online ahead of print.PMID: 36519564
Level 1, Impact factor 3.027

Risk Factors for Metachronous Colorectal Cancer or Advanced Adenomas After Endoscopic Resection of High-risk Adenomas.

Baile-Maxía S, Mangas-Sanjuán C, Ladabaum U, Hassan C, Rutter MD, Bretthauer M, Medina-Prado L, Sala-Miquel N, Pomares OM, Zapater P, Jover R. Clin Gastroenterol Hepatol. 2022 Dec 20:S1542-3565(22)01170-3. doi: 10.1016/j.cgh.2022.12.005. Online ahead of print.PMID: 36549471 Review.
Level 1, Impact factor 13.576

Reply to: Letter to the Editor regarding "Covid-19 transmission in fitness centers in Norway-a randomized trial".

Helsingen LM, Løberg M, Bretthauer M, Kalager M. BMC Public Health. 2022 Dec 27;22(1):2437. doi: 10.1186/s12889-022-14799-x.PMID: 36575428 Free PMC article. Clinical Trial.
Level 1, Impact factor 4.135

Detrimental Detection of Advanced Lesions With AI: False Confidence or Prevalence Bias? 

Hassan C, Mori Y, Sharma P, Spadaccini M, Repici A. Am J Gastroenterol. 2022 Dec 1;117(12):2088-2089. doi: 10.14309/ajg.0000000000002023. PMID: 36148842 No abstract available.
Level 2, Impact factor 10.864

Endoscopic full-thickness resection for complex colorectal lesions - what's the next step? 

Ichimasa K, Kudo SE, Koh CJ, Yeoh KG, Mori Y. Scand J Gastroenterol. 2022 Dec;57(12):1531-1532. doi: 10.1080/00365521.2022.2089858. Epub 2022 Jun 20. PMID: 35723915 No abstract available.
Level 1, Impact factor 3.027

Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study.

Ahlberg MS, Garmo H, Adami HO, Andrén O, Johansson JE, Steineck G, Holmberg L, Bill-Axelson A. BMJ Open. 2022 Dec 29;12(12):e057242. doi: 10.1136/bmjopen-2021-057242. PMID: 36581423; PMCID: PMC9806038.
Level 1, Impact factor 3.007

Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes.

Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, Smedby KE, Kleinstern G, Hjalgrim H, Besson C, Skibola CF, Morton LM, Brooks-Wilson AR, Teras LR, Breeze C, Arias J, Adami HO, Albanes D, Anderson KC, Ansell SM, Bassig B, Becker N, Bhatti P, Birmann BM, Boffetta P, Bracci PM, Brennan P, Brown EE, Burdett L, Cannon-Albright LA, Chang ET, Chiu BCH, Chung CC, Clavel J, Cocco P, Colditz G, Conde L, Conti DV, Cox DG, Curtin K, Casabonne D, De Vivo I, Diver WR, Dogan A, Edlund CK, Foretova L, Fraumeni JF Jr, Gabbas A, Ghesquières H, Giles GG, Glaser S, Glenn M, Glimelius B, Gu J, Habermann TM, Haiman CA, Haioun C, Hofmann JN, Holford TR, Holly EA, Hutchinson A, Izhar A, Jackson RD, Jarrett RF, Kaaks R, Kane E, Kolonel LN, Kong Y, Kraft P, Kricker A, Lake A, Lan Q, Lawrence C, Li D, Liebow M, Link BK, Magnani C, Maynadie M, McKay J, Melbye M, Miligi L, Milne RL, Molina TJ, Monnereau A, Montalvan R, North KE, Novak AJ, Onel K, Purdue MP, Rand KA, Riboli E, Riby J, Roman E, Salles G, Sborov DW, Severson RK, Shanafelt TD, Smith MT, Smith A, Song KW, Song L, Southey MC, Spinelli JJ, Staines A, Stephens D, Sutherland HJ, Tkachuk K, Thompson CA, Tilly H, Tinker LF, Travis RC, Turner J, Vachon CM, Vajdic CM, Van Den Berg A, Van Den Berg DJ, Vermeulen RCH, Vineis P, Wang SS, Weiderpass E, Weiner GJ, Weinstein S, Doo NW, Ye Y, Yeager M, Yu K, Zeleniuch-Jacquotte A, Zhang Y, Zheng T, Ziv E, Sampson J, Chatterjee N, Offit K, Cozen W, Wu X, Cerhan JR, Chanock SJ, Slager SL, Rothman N.. Leukemia. 2022 Dec;36(12):2835-2844. doi: 10.1038/s41375-022-01711-0. Epub 2022 Oct 22. PMID: 36273105.
Level 2, Impact factor 12.883

Expected value of artificial intelligence in gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.

Messmann H, Bisschops R, Antonelli G, Libânio D, Sinonquel P, Abdelrahim M, Ahmad OF, Areia M, Bergman JJGHM, Bhandari P, Boskoski I, Dekker E, Domagk D, Ebigbo A, Eelbode T, Eliakim R, Häfner M, Haidry RJ, Jover R, Kaminski MF, Kuvaev R, Mori Y, Palazzo M, Repici A, Rondonotti E, Rutter MD, Saito Y, Sharma P, Spada C, Spadaccini M, Veitch A, Gralnek IM, Hassan C, Dinis-Ribeiro M. Endoscopy. 2022 Dec;54(12):1211-1231. doi: 10.1055/a-1950-5694. Epub 2022 Oct 21. PMID: 36270318.
Level 2, Impact factor 10.437

Open access database for artificial intelligence research.

Halvorsen N, Mori Y. Gastrointest Endosc. 2023 Feb;97(2):200-201. doi: 10.1016/j.gie.2022.10.020. Epub 2022 Dec 23. PMID: 36567202. No abstract available.
Level 2, Impact factor 10.3963

Comparison of Quality Measures for Detection of Neoplasia at Screening Colonoscopy.

Wieszczy P, Bugajski M, Januszewicz W, Rupinska M, Szlak J, Pisera M, Turkot MH, Rupinski M, Wojciechowska U, Didkowska J, Regula J, Kaminski MF. Clin Gastroenterol Hepatol. 2023 Jan;21(1):200-209.e6. doi: 10.1016/j.cgh.2022.03.023. Epub 2022 Mar 24. PMID: 35341951.
Level 1, Impact factor 13.576

Comment. Letter to the Editor.

Øyvind Bakken Rognstad, Siri Kaldenbach, Tor A. Strand. Eur J Prev Cardiol. 2022 Mar 30;29(4):e168-e169. doi: 10.1093/eurjpc/zwab129. doi: 10.1093/eurjpc/zwab129. PMID: 34436581. No abstract available
Level 2, Impact factor 8.526